跳转至内容
Merck
CN

P1793

匹莫齐特

≥98% (TLC), powder, D₂ dopamine receptor antagonist

别名:

1-[1-[4,4-双(4-氟苯基)丁基]-4-哌啶基]-1,3-二氢-2H-苯并咪唑-2-酮

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C28H29F2N3O
化学文摘社编号:
分子量:
461.55
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
218-171-7
MDL number:
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

匹莫齐特,

form

powder

Quality Level

solubility

DMSO: 18 mg/mL(lit.), chloroform: 5 mg/mL, H2O: insoluble(lit.)

originator

Teva

storage temp.

2-8°C

SMILES string

Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5

InChI

1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)

InChI key

YVUQSNJEYSNKRX-UHFFFAOYSA-N

Biochem/physiol Actions

D 2 多巴胺受体拮抗剂;与克隆的 5-HT 7 受体高亲和力结合;Ca 2 + 通道拮抗剂;抗精神病药

Features and Benefits

该化合物在受体分类和信号转导手册的环核苷酸门控(CNG)和超极化激活的环核苷酸门控(HCN)通道页面上有详细描述。想要浏览手册的其他页面, 请单击此处
该化合物是环核苷酸研究的特色产品。 点击此处 ,发现更多特色环核苷酸产品。。在 sigma.com/discover-bsm了解更多关于其他研究领域的生物活性小分子。
该化合物由 Teva 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处


Still not finding the right product?

Explore all of our products under 匹莫齐特


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Cyclic nucleotides like cAMP modulate cell function via PKA activation and ion channels.


Joseph I Friedman et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 36(6), 1289-1295 (2011-02-25)
Despite its superior efficacy, clozapine is helpful in only a subset of patients with schizophrenia unresponsive to other antipsychotics. This lack of complete success has prompted the frequent use of various clozapine combination strategies despite a paucity of evidence from
Junjun Chen et al.
Chemistry & biology, 18(11), 1390-1400 (2011-11-29)
Ubiquitin-specific proteases (USPs) have in recent years emerged as a promising therapeutic target class. We identified selective small-molecule inhibitors against a deubiquitinase complex, the human USP1/UAF1, through quantitative high throughput screening (qHTS) of a collection of bioactive molecules. The top
Holger H H Erb et al.
PloS one, 15(8), e0237248-e0237248 (2020-08-14)
Despite enzalutamide's efficacy in delaying the progression of metastatic castration-resistant prostate cancer (CRPC), resistance to this anti-androgen inevitably occurs. Several studies have revealed that the signal transducer and activator of transcription (STAT) 5 plays a role in tumour progression and



全球贸易项目编号

货号GTIN
P1793-1G04061825982625
P1793-500MG04061832092553